The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Modulation of Protein–Protein Interactions with Small Organic Molecules
Abstract
Many proteins exert their biological roles as components of complexes, and the functions of proteins are often determined by their specific interactions with other proteins. Because of the central importance of protein–protein interactions for cellular processes, the ability to interfere with specific protein–protein interactions provides a powerful means of influencing the function of selected proteins within the cell. Cell‐permeable small organic modulators of protein–protein interactions are thus highly desirable tools both for the study of physiological cellular processes and for the treatment of numerous diseased states. Herein a number of protein–protein interactions that are considered to be pharmaceutical targets are presented, which will familiarize the reader with the strategies that have been employed for the successful identification of small molecule modulators of these protein–protein interactions. These encouraging examples suggest that combined research efforts in the areas of functional proteomics, assay development, and organic synthesis will open up novel possibilities for the treatment of human diseases in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–212 of 212
Furchgott, R. F. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990712)111:13/14<1990::aid-ange1990>3.0.co;2-5 · Cited by 32
Platelet Aggregation Inhibition with Glycoprotein IIb–IIIa Inhibitors
Proimos, G. (2001) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1011216414539 · Cited by 31
Moss, N., Beaulieu, P. L., Duceppe, J., Ferland, J., Gauthier, J. B., Ghiro, E., Goulet, S., Grenier, L., Llinàs‐Brunet, M., Plante, R., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00018a022 · Cited by 29
Spivak, J. L. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001331 · Cited by 29
Pei, Z., Xin, Z., Liu, G., Li, Y., Reilly, E. B., Lubbers, N. L., Huth, J. R., Link, J. T., von Geldern, T. W., Cox, B. F., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010059w · Cited by 28
Restricting the flexibility of crosslinked, interfacial peptide inhibitors of HIV-1 protease
Ulysse, L. G., & Chmielewski, J. A. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00595-2 · Cited by 24
Stickstoffmonoxid: die rätselhafte Chemie eines biologischen Botenstoffes
Pfeiffer, S., Mayer, B., & Hemmens, B. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990614)111:12<1824::aid-ange1824>3.0.co;2-e · Cited by 23
Probing the role of interfacial residues in a dimerization inhibitor of HIV-1 protease
Shultz, M. D., & Chmielewski, J. A. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00400-x · Cited by 22
Inhibitors of protein-protein interactions
Gadek, T. R., & Ockey, D. A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.3.393 · Cited by 21
García-Echeverría, C., Furet, P., & Chêne, P. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00394-8 · Cited by 14
T Cell Homeostasis and Autoreactivity in Rheumatoid Arthritis
Goronzy, J. J., & Weyand, C. M. (2000) · KARGER eBooks · doi:10.1159/000060516 · Cited by 13
T-cell Tolerance and Autoimmune Diabetes
Brumeanu, T., Bona, C. A., & Casares, S. A. (2001) · International Reviews of Immunology · doi:10.3109/08830180109043041 · Cited by 10
Cited by
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Thirumurugan, P., Matosiuk, D., & Jozwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,896
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
“For these reasons, protein–protein interactions have been of great interest to drug discovery; however, developing small-molecule antagonists has been difficult (for recent reviews see Ref”
BackgroundPotential therapeutic applications of autophagy
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., & Klionsky, D. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2272 · Cited by 862
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
Small-Molecule Inhibition of TNF-α
He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 620
Metadata
- Authors
- Berg, T.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2003-06-05
- Volume
- 42
- Issue
- 22
- Pages
- 2462-2481
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W1998492578
- Cited by
- 292
- References
- 212
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.